Future Science Group VISION IN STM PUBLISHING [ BARBARA VALCELLI / ACCUCOMS
|
|
|
- Rosamund Bennett
- 5 years ago
- Views:
Transcription
1 Future Science Group VISION IN STM PUBLISHING [ BARBARA VALCELLI / ACCUCOMS BARBARA@ACCUCOMS.COM
2 Publisher of journals, ebooks and ecommunities Introducing Future Science Group About Future Science Group (FSG) Journals ebooks ecommunities Contact [Barbara Valcelli 2
3 Publisher of Journals, ebooks and ecommunities ABOUT FUTURE SCIENCE GROUP Progressive publisher focusing on breakthrough medical, biotechnological and scientific research Advancing clinical practice and drug research by enhancing communication Publish journals, ebooks and ecommunities through two imprints- Future Medicine and Future Science Headquartered in London, global in outlook, independent in spirit 3
4 Future Medicine Journals
5 Publisher of Journals, ebooks and ecommunities BENEFITS OF THE FUTURE SCIENCE GROUP JOURNAL COLLECTION Covering niche areas of research in emerging fields such as Nanomedicine (IF: 5.824) and Regenerative Medicine (IF: 3.5) MEDLINE indexed High impact factored Leading experts shape our journal content Editorial board members represent the world s most prestigious oganizations, Including; National Institutes of Health, USA Cedars-Sinai Medical Center, USA Harvard University, USA Cancer Research UK, UK University College London,UK Cambridge University, UK Karolinska Institute, Sweden Leiden University, The Netherlands National Cancer Center, Japan Seoul National University, Korea Peking University, China 5
6 Cutting-edge coverage of postgenomic scientific and medical information Future Medicine Collection 28 journals Future Medicine Essentials Nanomedicine Regenerative Medicine Pharmacogenomics & Personalized Medicine Future Series Future Cardiology Future Microbiology Future Neurology Future Oncology Future Virology Additional Journals Clinical Lipidology Diabetes Management Intl Journal of Clinical Rheumatology Interventional Cardiology Pain Management Women s Health Oncology Collection Breast Cancer Management Hepatic Oncology Intl Journal of Endocrine Oncology Intl Journal of Hematologic Oncology Lung Cancer Management Melanoma Management CNS Oncology Colorectal Cancer Journals for the post-genomic era Biomarkers in Medicine Epigenomics Immunotherapy Journal of Comparative Effectiveness Research Neurodegenerative Disease Management
7 Information needs in clinical and translational medicine and the biosciences Future Medicine Essentials The three journals in the Future Medicine Essentials series represent three of the fastest growing areas of bioscience. Amongst the first journals in their respective fields, these journals feature high Impact Factors, MEDLINE-indexing and significant readership. Pharmacogenomics MEDLINE-indexed Impact Factor: issues per year 20,930 abstract views/month Research and comment on the role of genetics in drug response Nanomedicine MEDLINE-indexed Impact Factor: issues per year 26,364 abstract views/month Advances in medical nanoscale-structured material and devices Regenerative Medicine MEDLINE-indexed Impact Factor: issues per year 11,015 abstract views/month Up-to-date research for the translation of stem cell therapies from the laboratory to patients 7
8 Information needs in clinical and translational medicine and the biosciences Future Series The journals in the Future Series adopt a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in a new era of care. Delivered in a concise format, Future Series journals are shaped to meet the needs of timeconstrained practitioners and policy-makers. Future Microbiology MEDLINE-indexed Impact Factor: issues per year 17,450 abstract views/month Covers microbiological areas including all pathogen types and microbe host interactions Future Oncology MEDLINE-indexed Impact Factor: issues per year 22,555 abstract views/month Provides updates on oncology research, ranging from the bench to the bedside Associated ecommunity: Oncology Central Future Virology Impact Factor: issues per year 4075 abstract views/month Latest updates in virology, infectious disease and immunology analysis 8
9 MEDLINE-indexed journals for the post-genomic era Epigenomics MEDLINE-indexed Impact Factor: issues per year 7435 abstract views/month Focus on the description and deciphering of genome-wide interactions Journal of Comparative Effectiveness Research MEDLINE-indexed Impact Factor: issues per year 2250 abstract views/month The only MEDLINE-indexed journal focused specifically on comparative effectiveness research 9
10 Future Science Journals
11 Cutting-edge coverage of postgenomic scientific and medical information Future Science Collection 6 Journals, 27 ebooks Last 12 months: 1.3 million page views 340,000 users 520,000 abstract views Journals Bioanalysis Clinical Investigation Future Medicinal Chemistry Pharmaceutical Bioprocessing Pharmaceutical Patent Analyst Therapeutic Delivery 230,000 full-text downloads
12 Applied science and intellectual property issues in R&D Future Science Essentials Bioanalysis MEDLINE-indexed Impact Factor: issues per year 16,900 abstract views/month Scientific, technical and regulatory developments in bioanalysis Future Medicinal Chemistry MEDLINE-indexed Impact Factor: issues per year 12,550 abstract views/month Design of small-molecule bioactive agents and the identification of therapeutic targets
13 ebooks
14 Specifically designed to enhance comprehension and aid learning BENEFITS OF THE FUTURE SCIENCE GROUP EBOOK COLLECTION No DRM One-time purchase with no additional maintenance fee Multiple simultaneous access Perpetual access to the purchased content Free MARC records for easy integration into your library catalogue COUNTER compliant usage statistics Flexible purchase options collections and individual titles 14
15 THE E-BOOK COLLECTION Low cost coverage of a broad range of topics Neurology Analytical Chemistry Immunology Oncology Pharmaceutical Science Cardiology Environmental Science Infection 15
16 ecommunities
17 Specifically designed to enhance comprehension and aid learning BENEFITS OF THE FUTURE SCIENCE GROUP E-COMMUNITIES Free-of-charge online information centres built to meet the specific needs of niche scientific and medical communities Offers easy access to breaking news, developments and peer-reviewed articles Provides a unique and unparalleled platform for medical communities to share insights, discuss the latest research, and help move the field forward Benefits from the experience and support of the Future Science Group editorial team who are involved in news, reviews and engaging discussions. 17
18 Specifically designed to enhance comprehension and aid learning Bioanalysis Zone is the online home of Bioanalysis, bringing together: The latest news, views, research and products A forum for the community to discuss the development of this fast-moving field Topical webinars on new technology and scientific advances Peer-reviewed content from the Bioanalysis journal (MEDLINE-indexed, IF 3.027) 18
19 Specifically designed to enhance comprehension and aid learning RegMedNet is the source of a range of regenerative information focusing on: Translational science Covering hot topics such as regulation, clinical trials, stem cell tourism, and industry news. Building and empowering knowledge Providing members with access to free information and resources easily and efficiently. 19
20 Specifically designed to enhance comprehension and aid learning Oncology Central is an online resource powered by Future Science Group and provides: Help for members to stay up-to-date with industry developments. A platform exclusively for medical professionals with an interest in oncology, endorsed by an expanding board of expert Ambassadors from across the globe. Access to select journal articles recently published across all the FSG titles. A tailored homepage, regular news updates and exciting multimedia content. 20
21 Sales Representative Italy Contact: Barbara Valcelli Accucoms International BV Trials, quotes on request. 21
Header. Future Science Group. Catalogue 2019
Header Future Science Group Catalogue 2019 1 Section Header 2 For more information visit www.future-science-group.com Contents Page Our Journal Portfolio 2 Future Medicine At-A-Glance 3 Future Science
Adis Journals and Newsletters The premier collection of drug-focused medical journals
adis.com Adis Journals and Newsletters The premier collection of drug-focused medical journals An invaluable resource for all involved in medical research, practice or teaching, drug regulation or reimbursement,
List of E-journals Subscribed for the year 2016 (January to December) Pharmacy Faculty Sl. No.
Faculty 1 Adolescent Psychiatry Psychiatry 2 Anti Cancer Agents in Medicinal / Pharma & Quality 3 Anti-Infective Agents Pharmaceutical Microbiology 4 Anti-Inflammatory & Anti- Allergy Agents in Medicinal
EXPERT COLLECTION. Explore our leading medical review series
EXPERT COLLECTION Explore our leading medical review series Introducing the EXPERT COLLECTION The Taylor & Francis Expert Collection is the world s largest series of review journals in research, development,
3rd Global Congress On Medical & Clinical Case Reports Theme: Medical & Clinical Exploration By Global Experts About the Conference: Aim
3rd Global Congress On Medical & Clinical Case Reports Theme: Medical & Clinical Exploration By Global Experts About the Conference: Gavin Conferences invites participants from all over the world to attend
Springer Protocols. springer.com. Introducing the world s most comprehensive collection of peer-reviewed life sciences protocols
springer.com Springer Protocols Introducing the world s most comprehensive collection of peer-reviewed life sciences protocols 7 More than 18,000 protocols with an additional 2,000 added each year 7 Based
Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight. Daria Iovcheva November, 2017
Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight Daria Iovcheva November, 2017 1 Contents 1.0 About Springer Nature and our platforms 2.0 Nature Research Journals:
Pharmaceuticals and Biotechnology
ABCD Pharmaceuticals and yet are quickly accessible from one central location. 7 Gain a competitive advantage 7 Facilitate product research and development 7 Raise return on investment Pharmaceuticals
A bold vision for 2025
Leading the Biomedical Revolution in Precision Health: How Stanford Medicine is Developing the Next Generation of Health Annual Stanford Medicine Population Health Sciences Colloquium October 26, 2015
future science group Catalogue
future science group Catalogue 2013 www.future-science-group.com What are you looking for? Future Medicine Journals 26 58 Tomorrow s medicine today 29 journals providing cutting-edge coverage of postgenomic
Roche, Roche Molecular Diagnostics and more
, Molecular and more [Monte Wetzel, PhD] Patients have questions. We provide answers. Group Clear focus on Healthcare Innovation with two strong pillars Pharma Pharma Genentech Chugai Molecular Professional
BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
: TECHNOLOGIES AND GLOBAL MARKETS BIO061C April 2014 Jackson Highsmith Project Analyst ISBN: 1-56965-801-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within
Roche in Australia Innovation Leader
Roche in Australia Innovation Leader About Roche Innovation: it s in our DNA 7,000,874 hours of work 6,587 experiments 423 researchers 1 drug For nearly 120 years, Roche has been committed to improving
Let us empower you to be a pharmacovigilance superhero...
Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that can be used for many different pharmacovigilance activities. Pharmacovigilance
SciTechnol Mediakit. MatheMatics. Research and Reports on. Research Journal of Clinical Pediatrics
SciTechnol Mediakit Research Journal of Clinical Pediatrics Research and Reports on MatheMatics www.scitechnol.com www.scitechnol.com Our Vision To publish, promote and disseminate the work of medical
future science group CATALOGUE
future science group CATALOGUE 2014 www.future-science-group.com Contents Welcome 2 Subject collections 4 Future Medicine Journals 11 Biomarkers in Medicine 14 Breast Cancer Management 15 Clinical Lipidology
Konica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion
News Release Konica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion Advances Konica Minolta strategy to establish a leadership position in precision medicine Contributes
New Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation
New Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation Dr. Klaus Suwelack Johnson & Johnson Innovation, Janssen-Cilag Germany, Neuss
A CLOSER LOOK GBL/COR/0916/1075 U.S
A CLOSER LOOK AbbVie: An Introduction We re a biopharmaceutical company. We re guided by people, powered by passion, and in awe of the possibilities ahead of us. We re highly focused, research oriented,
Course Agenda. Day One
Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an
CENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
CENTRAL NERVOUS SYSTEM (CNS) : TECHNOLOGIES AND GLOBAL MARKETS BIO074C March 2016 Jackson Highsmith Project Analyst ISBN: 1-62296-246-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
P ULSUS Publishing Medical Research Since 1984
Overview Our Vision 34 Years Publishing Medical Research To publish, promote and disseminate the work of medical researchers in a manner that exemplifies the highest standards in research integrity Research
Journal Of Molecular Medicine Authorship Statement
Journal Of Molecular Medicine Authorship Statement American Journal of Respiratory and Critical Care Medicine Care Units An Official American Thoracic Society Statement: The Importance of Healthy Sleep.
Molecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
Information Day Leeds, UK 27 October 2015 Treating and managing disease
The societal challenge 'Health, demographic change and well-being' Work programme 2016-2017 Information Day Leeds, UK 27 October 2015 Treating and managing disease Image credit: Adam Fagen Rallying for
In 2016, around 86% of fully open access journals have an APC. The APC average is 1084 USD.
SAGE Publisher 2017 Data analysis by Katherine Laprade Story SAGE, which defines itself as the world s largest independent academic publisher on its website, bought Libertas Academica in 2016, which is
CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY
CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY Executive Summary Prepared for Applied Biological Technologies Initiative Economic and Workforce Development Program California
IMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager
IMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager Introducing IMI2: Vienna 16 July 2014 The way in which pharmaceutical companies develop new medicines
From IMI to IMI2 new models of collaborative research. Magda Chlebus, Science Policy, EFPIA Ljubljana, 23 May 2014
From IMI to IMI2 new models of collaborative research Magda Chlebus, Science Policy, EFPIA Ljubljana, 23 May 2014 What is IMI and how does it work? Innovative Medicines Initiative: Joining Forces in the
Happy 30 th Birthday DBT!!
Happy 30 th Birthday DBT!! Thank you for nurturing India s Bioscience and Biotech You have been Interdisciplinary Empowering Entrepreneurial Adaptive Thoughtful risk taker A connector par excellence Nationally
AdenoVerse Platform for Translational Development of Innovative Gene and Cell Therapies Cell & Gene Therapy World January 18, 2017
AdenoVerse Platform for Translational Development of Innovative Gene and Cell Therapies Cell & Gene Therapy World Douglas E. Brough, Ph.D. Chief Scientific Officer Safe Harbor Statement Statements herein
BMC Media Kit. Open-access research that covers a broad range of disciplines, and reaches influencers and decision makers.
2018 Media Kit BMC Open-access research that covers a broad range of disciplines, and reaches influencers and decision makers. LIFE & BIOMEDICAL SCIENCES BIOTECHNOLOGY & APPLIED MICROBIOLOGY CELL BIOLOGY
THE GLOBAL MARKET FOR STEM CELLS
THE GLOBAL MARKET FOR STEM CELLS BIO035F May 2016 Paul Evers Project Analyst ISBN: 1-62296-292-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within the USA),
A D V A N C I N G I N N O V A T I O N I N H E A L T H C A R E Partners Innovation Fund
A D V A N C I N G I N N O V A T I O N I N H E A L T H C A R E Partners Innovation Fund Partners HealthCare July 2017 P A R T N E R S I N N O V A T I O N F U N D In Brief Capitalization $165M fund $100
EU support for Health Research from FP6 to FP7
EU support for Health Research from FP6 to FP7 Stéphane Hogan Head of Biotechnology Unit Directorate for Health Research DG Research - European Commission Valencia - 15 September 2006 EU research programmes
Early Patient Studies in Evolution. John Horkulak Executive Director, Eurasian External Study Operations Feb 23, 2015
Early Patient Studies in Evolution John Horkulak Executive Director, Eurasian External Study Operations Feb 23, 2015 Questions How are early phase studies evolving and why the push for studying patients
Adis Journals Overview
Adis Journals Overview Introduction Adis Rapid Publishing Service Life after publication AdisOnline.com The Adis publishing heritage The Adis Journals brand has evolved over 40 years to become synonymous
FP7 Cooperation Work Programme: Health-2011 Topics and contact points
FP7 Cooperation Work Programme: Health-2011 Topics and contact points Date of publication: 30 July 2010 Call identifiers: Indicative budgets Deadlines FP7-HEALTH-2011-single-stage EUR 160.5 million 10
Exemplary Project. COILED THE NETHERLANDS April 2018
Exemplary Project COILED THE NETHERLANDS April 2018 This document was prepared as part of the EU-funded project: ESIF Support in the area of health: building knowledge and capacities for monitoring and
ABOUT GLYCOSTEM. Company Overview
ABOUT GLYCOSTEM The company is a clinical stage biotech company established in the Netherlands in 2007. The company s headquarters and new state-of-the-art lab and production facilities are based at Pivot
Global Allied Pharmaceuticals, LLC. Innovation, Research, and Technology. Breaking the bounders, first in its class, thinking outside the box.
Global Allied Pharmaceuticals, LLC. Innovation, Research, and Technology. Breaking the bounders, first in its class, thinking outside the box. The purpose of this presentation Looking for Joint Venture
ADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY BACHELOR OF SCIENCE (Honours) SEMESTER - I
NEW CHOICE BASED CREDIT SYSTEM (TOTAL CREDIT = 22+22+28+28+26+26 = 152) Type of the Paper Paper Code ADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY SEMESTER - I / Brief Contents I BT1201
Japan s share of research output in basic medical science. Mahbubur Rahman, Junichi Sakamoto and Tsuguya Fukui1
ORIGINAL ARTICLE Japan s share of research output in basic medical science Mahbubur Rahman, Junichi Sakamoto and Tsuguya Fukui1 Department of Epidemiological and Clinical Research Information Management,
Company Profile. German-Taiwan Biotech Seminar 6 November 2017
Company Profile German-Taiwan Biotech Seminar 6 November 2017 Our Mission Bayer: Science For A Better Life A growing and aging world population requires an adequate supply of food and improved medical
Antibody Discovery at Evotec
Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic
Annual General Meeting Roche Holding Ltd 14 March 2017
Annual General Meeting Roche Holding Ltd 14 March 2017 Address by Christoph Franz Chairman of the Board of Directors (Check against delivery) Address Christoph Franz Page 2/10 Dear Shareholders, Ladies
Food and Agriculture
ABCD Food and Agriculture yet are quickly accessible from one central location. 7 Gain a competitive advantage 7 Facilitate product research and development 7 Raise return on investment Food and Agriculture:
HELPING DELIVER LIFE-CHANGING THERAPIES HEMATOLOGY ONCOLOGY
HELPING DELIVER LIFE-CHANGING THERAPIES HEMATOLOGY ONCOLOGY PROVIDING COMPREHENSIVE SOLUTIONS IN A COMPLEX ENVIRONMENT PPD IS A PARTNER WITH PROVEN CAPABILITIES THAT SUPPORT AND ADVANCE ONCOLOGY RESEARCH
J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION
J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION J ove VIDEO JOURNAL The first scientific video journal dedicated to advancing science by increasing reproducibility and efficient
MULTIDISCIPLINARY ACTIVITY IN THE HEALTHCARE MARKET
MULTIDISCIPLINARY ACTIVITY IN THE HEALTHCARE MARKET LOCATION Bydgoszcz We have two offices: in Bydgoszcz (head office) on the North and Katowice on the South of Poland. Since 2015 Bioscience has been a
"Stratification biomarkers in personalised medicine"
1/12 2/12 SUMMARY REPORT "Stratification biomarkers in personalised medicine" Workshop to clarify the scope for stratification biomarkers and to identify bottlenecks in the discovery and the use of such
New WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research
New WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research Hanne Bak Pedersen Programme Manager Health Technologies and Pharmaceuticals
2012 Rate Card. Look inside to leverage MPR s multi-channels for reaching your audience.
2012 Rate Card Look inside to leverage MPR s multi-channels for reaching your audience. 114 West 26th Street, 4th Floor, New York, NY 10001 Tel: (646) 638-6000 Fax: (646) 638-6119 empr.com empr.com = Concise,
Precision Medicine. Presented by:
Precision Medicine Presented by: Prepared Brendan FitzGerald For: Enabling better health through information technology. Healthcare Information and Management Systems Society (HIMSS) HIMSS is a global,
Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) READ ONLINE
Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) READ ONLINE to modify patients' exposure to drugs based on their genomic drug-response
EUROPEAN TECHNOLOGY PLATFORM NANOMEDICINE. Work plan for GA, 16th January 2008
Work plan for 2008 1 Vision In 10 years nanomedicinebased products will lead to breakthroughs in the treatment of diseases such as cardiovascular disease, cancer, CNS diseases and diabetes. 2 The ETP is
Impact Factor Journals in Biotechnology & Applied Microbiology
Impact Factor Journals in Biotechnology & Applied Microbiology Indexed in ISI Web of Knowledge (JCR 2016) Compiled by: Arslan Sheikh In Charge Reference & Research Section Library Information Services
Unicyte AG, regenerative medicine unit of Fresenius Medical Care, appoints world-leading experts to Scientific Advisory Board
Press Release Media Contact Martin Kunze T +49 6172 609-2115 martin.kunze@fresenius.com Contact for analysts and investors Dr. Dominik Heger T +49 6172 609-2601 dominik.heger@fmc-ag.com July 25, 2017 www.freseniusmedicalcare.com
STARTING STRONGER IN PHASE I THROUGH IIA
PAREXEL CLINICAL RESEARCH SERVICES: EARLY PHASE STARTING STRONGER IN PHASE I THROUGH IIA Adding value from first-in-human through proof-of-concept YOUR JOURNEY. OUR MISSION. Achieve success through early
News For Immediate Release
News For Immediate Release Contact: Gary Gatyas IMS Institute for Healthcare Informatics (610) 244-2600 ggatyas@us.imshealth.com IMS Study Forecasts Rebound in Global Spending on Medicines, Reaching Nearly
Policy principles for a competitive healthcare environment
Policy principles for a competitive healthcare environment Pharmaceutical Research and Development Industry Malta Association (PRIMA) PRIMA is an affiliate of the European Federation of Pharmaceutical
European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York
European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York OVERVIEW Creating the European RM Universe of firms Characterizing the European RM Universe Strategic
Cardiac Safety Research Consortium Annual Meeting. Future Areas of Focus & Opportunities 18 October 2016
Cardiac Safety Research Consortium Annual Meeting Future Areas of Focus & Opportunities 18 October 2016 CSRC MISSION To advance scientific knowledge on cardiac safety for new and existing medical products
The MiniSeq System. Explore the possibilities. Discover demonstrated NGS workflows for molecular biology applications.
The MiniSeq System. Explore the possibilities. Discover demonstrated NGS workflows for molecular biology applications. Let your work flow with Illumina NGS. The MiniSeq System delivers powerful and cost-effective
2018 Media Kit INDUSTRY-LEADING HCP REACH POWERFUL MOBILE SOLUTIONS PROVEN ROI
2018 Media Kit INDUSTRY-LEADING HCP REACH POWERFUL MOBILE SOLUTIONS PROVEN ROI Our Briefings Every morning, we deliver to more than 1 million physicians, dentists, and HCPs 900,000 of whom are U.S. based
How Targets Are Chosen. Chris Wayman 12 th April 2012
How Targets Are Chosen Chris Wayman 12 th April 2012 A few questions How many ideas does it take to make a medicine? 10 20 20-50 50-100 A few questions How long does it take to bring a product from bench
The Scientist Online. Reach. Segmentation. Technology. MEDIA KIT 2007
Customize your message MEDIA KIT 2007 The Scientist Online Multimedia Opportunities The-Scientist.com has a variety of technologies, positions and sponsorships designed to deliver your message as efficiently
of Innovative Pharmaceuticals* and Takao Inoue 4
26G-ISMS44 Regulatory Science for R&D Promotion Kazuhiko Mori 1, Takao Yamori 2, Toru Kawanishi 3, 1 Ministry of Health, Labor and Welfare (MHLW), 2 Pharmaceuticals and Medical Devices Agency (PMDA), 3
Press Release. Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics ViraTherapeutics
Research Xchange Forum 2018
Research Xchange Forum 2018 Insights Translation Solutions Trends and Challenges in Regenerative Medicine & Cell Therapy March 20 21, 2018 Sartorius Goettingen, Germany What to expect Learn about the latest
S&T Publications Output of India: A Scientometric Analyses of Publications Output,
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Library Philosophy and Practice (e-journal) Libraries at University of Nebraska-Lincoln April 2013 S&T Publications Output
S&T Publications Output of India: A Scientometric Analyses of Publications Output,
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Library Philosophy and Practice (e-journal) Libraries at University of Nebraska-Lincoln April 2013 S&T Publications Output
PhRMA Days Press Conference
PhRMA Days Press Conference April 12, 2017 Joaquin Duato Chairman of the Board, PhRMA Roadmap I. Recent Developments in the United States II. Biopharmaceutical Industry s Contribution to Innovation and
Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013
Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013 Indicative list Proposed topic /11 /11 /11 Identification and validation of innovative clinical endpoints for Osteoarthritis European genotype-phenotype
Opportunities for industry/smes in EU-funded health research
Opportunities for industry/smes in EU-funded health research Stéphane Hogan, M.Sc, MBA Head of Unit Applied Genomics and Biotechnology for Health DG Research - European Commission 1 Paris, 31 May 2005
Joint Technology Initiative: Innovative Medicine Initiative
Joint Technology Initiative: Innovative Medicine Initiative Dr John E Butler-Ransohoff Global External Innovation and Alliances Bayer HealthCare AG, Berlin/Wuppertal Bari, 30 April 2015 Largest Public
EY Life Sciences. Key themes from The Next Frontiers in Precision Medicine panel. February 2016
EY Life Sciences Key themes from The Next Frontiers in Precision Medicine panel February 2016 Evolution of precision medicine One-size-fits-all therapeutics Precision medicine Disconnected health care
New Health Data Economy: Strategic Partnerships with Life Sciences Company
New Health Data Economy: Strategic Partnerships with Life Sciences Company Pravin R Jadhav Sr. Director, Innovative Data Solutions Otsuka Data Sciences Otsuka Pharmaceutical Development and Commercialization
Personalised medicine: paradigm shift in the pharma business
Personalised medicine: paradigm shift in the pharma business This text first appeared in the IAM magazine supplement IP Value in the life sciences industries February 2006 For further information please
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC To Our Potential Partners We offer partners the depth of
BIOMEDICAL RESEARCH CENTRES
Introduction BIOMEDICAL RESEARCH CENTRES The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
Personalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)
Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome
NIH-RAID: A ROADMAP Program
NIH-RAID: A ROADMAP Program (Rapid Access to Interventional Development} A Program designed to facilitate the development of new therapeutics The NIH-RAID Pilot Program is intended to reduce some of the
the clinical research institute at RAMBAM
the clinical research institute at RAMBAM A commitment to science. A commitment to life. One of the greatest challenges facing today s leading healthcare institutions is the identification of the clinical
LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017
LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017 Lauren Becnel, Ph.D. VP, Biomedical Informatics & Alliances, CDISC Asst Prof, Duncan Comprehensive Cancer Center,
Biotechnology Certificate New Technologies For Health
Weekly Barometer 25 janvier 2012 Biotechnology Certificate New Technologies For Health January 2018 ATONRÂ PARTNERS SA 12, Rue Pierre Fatio 1204 GENEVA SWITZERLAND - Tel: + 41 22 310 15 01 http://www.atonra.ch
PATHWAY TO VALUE CREATION NASDAQ: BNTC ASX: BLT
PATHWAY TO VALUE CREATION NASDAQ: BNTC ASX: BLT Annual General Meeting Presentation 8 November 2018 Jerel A. Banks, M.D., Ph.D. Chief Executive Officer and Executive Chairman SAFE HARBOR STATEMENT This
PATHWAY TO VALUE CREATION NASDAQ: BNTC ASX: BLT. For personal use only
PATHWAY TO VALUE CREATION NASDAQ: BNTC ASX: BLT Annual General Meeting Presentation 8 November 2018 Jerel A. Banks, M.D., Ph.D. Chief Executive Officer and Executive Chairman SAFE HARBOR STATEMENT This
Inaugural Fraunhofer Delaware Technology Summit
Inaugural Fraunhofer Delaware Technology Summit Energy and Life Sciences Solu
Prescription Medicines: Costs in Context
Prescription Medicines: Costs in Context 2018 We are in a new era of medicine where breakthrough science is transforming care with innovative treatment approaches... Then Now Medicines made of chemical
ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS
ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS 2018-2024 ORACLE 2.0: Leading Globally, from Innovation to Impact P1 P2 NOTE FROM OUR LEADERS NOTE FROM VP RESEARCH,
Working Together for Better Health Partnering with Boehringer Ingelheim. JOURNEE COLLABORATIVE DE LYONBIOPOLE October 10, 2017
Working Together for Better Health Partnering with Boehringer Ingelheim JOURNEE COLLABORATIVE DE LYONBIOPOLE October 10, 2017 Welcome to Partnering with Boehringer Ingelheim Our guiding principle Value
Eleventh Annual Chapel Hill Pharmaceutical Sciences Conference. Pharmacy in the Era of Precision Medicine: From Discovery to Implementation
Eleventh Annual Chapel Hill Pharmaceutical Sciences Conference Pharmacy in the Era of Precision Medicine: From Discovery to Implementation May 18 19, 2017 The Carolina Inn, Chapel Hill, NC Co-Chairs: Daniel
Innovative Medicines Initiative
Innovative Medicines Initiative EMA - EBE Regulatory Conference on ATMPs Salah-Dine Chibout, Novartis Global Head Discovery & Investigative Safety/ Global Head Preclinical Safety Therapeutic Areas IMI
EVOTEC REPORTS FIRST QUARTER 2018 RESULTS AND PROVIDES CORPORATE UPDATE
, 09 MAY 2018 EVOTEC REPORTS FIRST QUARTER 2018 RESULTS AND PROVIDES CORPORATE UPDATE 55% INCREASE IN GROUP REVENUES STRONG UNDERLYING OPERATIONAL PERFORMANCE WITH NEW BUSINESS MIX AFTER APTUIT ACQUISITION
Our job today Enlist you to help us cross the Translational Divide between the lab bench and the patient s bedside Demonstrate that this will
Bench Bedside Our job today Enlist you to help us cross the Translational Divide between the lab bench and the patient s bedside Demonstrate that this will be done in our Kimmel Cancer Center at Hopkins,
Free, open access to research. Membership Director. Becky Fishman. papers.
BioMed Central Free, open access to research papers Becky Fishman Membership Director becky@biomedcentral.com http://www.biomedcentral.com BioMed Central Independent online publishing house committed to
Harvard Stem Cell Institute
Welcome to the Harvard Stem Cell Institute The 1000+ scientists in the HSCI network share one goal: finding cures for human diseases. We aim to: Stimulate healing in patients by harnessing the potential